novo nordisk lawsuit semaglutide A Review of Nordisk's Ozempic and Wegovy Trademark Enforcement Campaign Novo Nordisk sues two pharmacies

The FDA label sets three eligibility rules: The patient must be 18 years or older

While this contributes to retatrutides weight loss efficacy, it also means your liver is already working harder on fat metabolism, potentially leaving less enzymatic capacity for alcohol processing

The era of easy arbitrage is over

Early rodent studies showed an increased rate of C-cell tumors after prolonged GLP-1 exposure

WATCH | WHO recommends GLP-1 therapies for obesity: Health Canada has also listed known risks associated with the use of genuine GLP-1 products, including severe gastrointestinal problems, pancreatitis, worsening kidney injury and low blood sugar, particularly if combined with other medications